Repare Therapeutics

Canada
Côte-Nord-du-Golfe-du-Saint-Laurent, Quebec, Canada, H4S 2A1

Company profile

Repare Therapeutics company profile

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells. The company's drugs combine a proprietary high throughput gene-editing and target discovery method with high-resolution protein crystallography, computational biology and clinical informatics, enabling patients to improve cancer treatment both with single therapy and in combination with existing drugs and treatments.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$50,000+
Founded
2016-01-01, Year

Headquarters

Postal code
H4S 2A1
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$251.7M
Last funding
Post IPO Equity / $101.2M / 2021-10-27
Last equity funding
Post IPO Equity / $101.2M
Investors
13
Lead investors
3
Founders
3
Articles
196
Exited on
2020-06-18

Founders and investors

Founders

Agnel SfeirDaniel DurocherFrank Sicheri

Lead investors

Cowen Healthcare InvestmentsMPM CapitalVersant Ventures

Investors

Business Development Bank of CanadaFonds de solidarité FTQOrbiMedRedmile GroupVersant Ventures